Vagus nerve stimulation for depression (2005)
After decades of animal research showing that electrically stimulating the vagus nerve alters brain circuits, the U.S. Food and Drug Administration approved vagus nerve stimulation as a treatment for treatment-resistant depression. A peripheral, non-brain intervention was proven capable of changing brain function in patients.
The approval validated the concept that stimulating a peripheral nerve or tissue could treat a central nervous system disorder safely.
It opened a regulatory and commercial pathway for device-based therapies that act on the brain through the body, which the bone compression device would follow.
Like vagus nerve stimulation, tibial compression is a mechanical, non-invasive intervention on a peripheral tissue that produces measurable brain changes — but delivered through the blood rather than through nerves.
